Following researches involving experimental interventions, levels of MMP-9 and MMP-14 can be used in the diagnosis and assessment of the severity and in treatments that can reduce or slow eye damage caused by diabetic retinopathy by suppressing the level of these proteins that represents the clinical contribution of this study. Here, MMP9 is linked to diabetic retinopathy.